Specialized Post-Incarceration Care for Opioid Addiction
(TCN-PATHS Trial)
Trial Summary
What is the purpose of this trial?
TCN PATHS will recruit an anticipated 400 participants who are prescribed MOUD who are released from detention facilities. Each individual will be randomized to either 1) standard primary care (SPC) or 2) a Transitions Clinic Network (TCN) program primary care. Participants will be followed for a year and complete surveys at baseline and at month 1, 3, 6, 9, and 12. At each of these points research staff will confirm MOUD status. Urine drug screenings will be completed at baseline, month 1, 6, and 12 if the participant is not incarcerated. When possible, research staff will collect electronic health records.
Do I have to stop taking my current medications for this trial?
The trial does not specify if you need to stop taking your current medications. However, since participants are required to be on MOUD (medications for opioid use disorder), it seems you may need to continue those medications.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants must be on MOUD (medications for opioid use disorder), so you may need to continue those.
What data supports the idea that Specialized Post-Incarceration Care for Opioid Addiction is an effective treatment?
The available research shows that Specialized Post-Incarceration Care for Opioid Addiction, like the Transitions Clinic Network, can be effective. For example, one study found that people released from jail who received care in a primary care setting had similar success in staying in treatment and avoiding opioid misuse as those referred from the community. Another study highlighted that early engagement in the Transitions Clinic Network led to fewer emergency visits for those referred by correctional partners. This suggests that such specialized care can help people stay healthier and avoid emergency situations.12345
What data supports the effectiveness of the treatment Transitions Clinic Network Primary Care for opioid addiction?
Research shows that the Transitions Clinic Network (TCN) helps people released from prison by improving their health through better primary care. Patients referred by correctional partners had fewer emergency visits, suggesting that TCN can effectively support individuals with chronic conditions, including opioid addiction, after incarceration.12345
What safety data exists for post-incarceration opioid addiction treatment in primary care?
The safety data for post-incarceration opioid addiction treatment in primary care settings includes studies on buprenorphine-naloxone maintenance. One study showed similar treatment retention and opioid abstinence rates between postrelease patients and community-referred patients in primary care. Another study evaluated a primary care-based transition clinic for patients initiated on buprenorphine in the emergency department, highlighting the role of multidisciplinary care in improving treatment linkage and retention. Additionally, nurse-sensitive indicators in office-based opioid treatment (OBOT) programs demonstrate effective care coordination and transition management, which are crucial for patient outcomes in primary care settings.12456
Is the Specialized Post-Incarceration Care for Opioid Addiction safe for humans?
Research shows that primary care settings, including those with specialized programs like the Transitions Clinic, are generally safe for individuals with opioid use disorder. These programs often involve medication-assisted treatment with buprenorphine, which has been shown to be safe and effective in maintaining treatment and reducing opioid misuse.12456
Is the Transitions Clinic Network Primary Care a promising treatment for opioid addiction after prison?
How does the Transitions Clinic Network Primary Care treatment differ from other treatments for opioid addiction?
The Transitions Clinic Network Primary Care treatment is unique because it focuses on providing specialized care for individuals recently released from incarceration, linking them to primary care and support services that address both medical and social needs. This approach includes community health workers with histories of incarceration, which helps improve care continuity and support reentry into the community, making it distinct from standard primary care options.13578
Research Team
Emily Wang, MD
Principal Investigator
Yale University
Eligibility Criteria
This trial is for adults over 18 with Opioid Use Disorder (OUD) who are on medication-assisted treatment and have been recently released from jail. Participants must speak English or Spanish, not be planning to relocate soon, and can't already have a primary care provider. Pregnant women or those needing opioids for pain management without OUD are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Enrollment
Participants complete the enrollment process while in jail, including recruitment, screening, consent, baseline assessments, and randomization
Treatment
Participants receive either standard primary care or Transitions Clinic Network (TCN) program primary care, with follow-up surveys and urine drug screenings at specified intervals
Follow-up
Participants are monitored for safety and effectiveness after treatment, including engagement and retention in OUD treatment
Treatment Details
Interventions
- Standard Primary Care
- Transitions Clinic Network Primary Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
University of North Carolina
Collaborator
University of Puerto Rico
Collaborator
University of Rochester
Collaborator
University of Miami
Collaborator
University of California, San Francisco
Collaborator
University of Connecticut
Collaborator
Albert Einstein College of Medicine
Collaborator
Hennepin Healthcare Research Institute
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator